Cranberry juice consumption is often recommended along with low-dose oral antibiotics for recurrent urinary tract infection (UTI) prophylaxis. Because multiple membrane transporters are involved in the intestinal absorption and renal excretion of β-lactam antibiotics, we evaluated the potential risk of pharmacokinetic interactions between cranberry juice and the β-lactams: amoxicillin and cefaclor. The amoxicillin-cranberry interaction was investigated in eighteen healthy women who received a single oral test dose of amoxicillin on four separate occasions: at 500 mg and 2 g with or without cranberry juice cocktail (8 oz) according to a crossover design. A parallel cefaclorcranberry juice interaction study was also conducted, in which 500 mg cefaclor was administered with or without cranberry juice cocktail (12 oz). Data were analyzed by noncompartmental methods and nonlinear mixed effects compartmental modeling. We conclude that concurrent use of cranberry juice had no significant effect on the extent of oral absorption and renal clearance of amoxicillin and cefaclor. However, delays in absorption of amoxicillin and cefaclor were observed. These results suggest that the use of cranberry juice at usual quantities is not likely to alter the pharmacokinetics of these two oral antibiotics in UTI prophylaxis. 
Introduction
Urinary tract infections (UTIs) are diagnosed at least once in approximately 50 to 60% of all women during their lifetime in the United States (12, 25) . The prevalence of UTI is significantly less in young men and increases in older age (11) . A considerable portion of the patients experiences multiple recurrences (1) . Long term low dose antibiotic therapy is often recommended as prophylaxis against recurring UTI for six months to a year or longer (29) . In addition to standard treatments of trimethoprimsulfamethoxazole and nitrofurantoin, β-lactams antibiotics are also prescribed in pediatric and adult patients with recurrent UTIs that are resistant to standard therapy and with appropriate susceptibility (25, 36, 37) .
Cranberry juice has been the most widely used natural remedy for UTIs in the past decades (14, 26) . Multiple clinical trials have demonstrated the benefit of prophylaxis against UTIs with daily cranberry juice cocktail (CJC) intake (containing 27% pure juice) (3, 15, 17, 31, 38) . Although cranberry juice is often used in combination with low dose oral antibiotic, little is known about its drug interaction potential. It is now known that fruit juices are capable of producing clinically significant drug interactions through the inhibition of carrier-mediated active transport (7) . For example, the absorption of fexofenadine (8) , talinolol (30) and celiprolol (22) was markedly reduced by the concurrent ingestion of grapefruit, orange and apple juices. Although the molecular mechanisms of intestinal transport remain largely unknown, furanocoumarins and bioflavonoids present in these juices were shown to be potent in vitro inhibitors of organic anion transporting polypeptides (OATPs) and are suggested to play a role in the observed juice interactions (8) . Grapefruit juice co-administration also led to two-fold on September 12, 2017 by guest http://aac.asm.org/ Downloaded from increase in nicotine renal clearance (14, 16) . These results suggest that fruit juice constituents and/or their byproducts, when present at sufficient concentration, may be capable of modulating transporter-mediated intestinal absorption and systemic disposition.
Despite their low lipophilicity and zwitterionic nature at physiological pH, both amoxicillin and cefaclor exhibit good oral bioavailability (23, 39) . There is ample evidence in the literature to suggest that carrier-mediated active transport plays an important role in the intestinal absorption of many β-lactam antibiotics (4) . We previously demonstrated the involvement of multiple drug transporters in the β-lactam disposition (18, 20) . Human oligopeptide transporter 1 (hPepT1) expressed on the intestinal mucosa brush border membrane transports both amoxicillin and cefaclor and may mediate their active intestinal absorption (20) . Renal apical transporter oligopeptide transporter 2 (hPepT2) also mediates efficient uptake transport of both antibiotics. In addition, we observed significant amoxicillin uptake by recombinant organic anion transporter 3 (hOAT3) in cell-based assays. OAT3 is primarily expressed in the basolateral domain of renal tubular epithelium. Our in vitro results suggest that these β-lactams may undergo active secretion as well as active reabsorption in the kidney (20) .
Similar to citrus juices, cranberry juice has a rich content of flavonoids and phenolic acids. Quercetin and benzoic acid are the major flavonoid and phenol acids in CJC (5) . Using a cell expression system, we observed concentration-dependent CJC inhibition of recombinant hPepT1-mediated cellular uptake of amoxicillin and cefaclor (data not shown). Hippuric acid, the major urinary metabolite of benzoic acid, was also shown to be a potent hOAT3 inhibitor (K i at 20 µM) and may be capable of inhibiting hOAT3-mediated amoxicillin secretion in vivo (6, 18, 35) .
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The emerging literature and our preliminary in vitro data led to the present hypothesis that cranberry juice constituents and/or their in vivo metabolites may interact with intestinal and renal drug transporters and alter the pharmacokinetics of amoxicillin and cefaclor. Accordingly, we investigated the potential juice-antibiotic interaction in a group of healthy women. The results of our study should clarify the risk, if any, in the event that oral β-lactam antibiotic is used with cranberry juice. 
Materials and Methods

Material
Study population
The studies were conducted at the University of Washington General Clinical Research Center. The study protocol and consent form were approved by the Institutional Review Board at the University of Washington. Because UTI is much more prevalent in women than men, we enrolled only female subjects in the studies. Two separate groups of eighteen healthy women enrolled in amoxicillin and cefaclor studies, respectively. Subjects had no known allergies to β-lactam antibiotics, no history of renal and liver diseases, and were not receiving concurrent medications except oral contraceptives (n=3 in amoxicillin study and n=2 in cefaclor study). All individuals provided written informed consent before participation. A sample size of 18 was on September 12, 2017 by guest http://aac.asm.org/ Downloaded from estimated to be sufficient for detecting at least a 25% differences in AUC and CL R with 80% power at α level of 0.05 with both amoxicillin and cefaclor.
Study design Subjects were instructed to abstain from eating citrus fruits and fruit juices for 7 days before and during the course of study. Food containing caffeine and alcoholic beverages were not permitted 24 hours before and during visits since caffeine and its metabolites are known to interfere with some transporter function (19, 27) .
Subjects were assigned to each of the four following treatments according to a fixed sequence crossover design: (i) 500 mg amoxicillin with 8 oz water, (ii) 500 mg amoxicillin with 8 oz CJC, (iii) 2 g amoxicillin with 8 oz water, and (iv) 2 g amoxicillin with 8 oz CJC. Each treatment was separated by a washout period of at least one-week.
Prior to each visit with juice treatment, subjects took an additional 8 oz CJC twice daily for two days to approximate chronic juice dosing. Two amoxicillin doses (500 mg and 2 g) were included in the study to differentiate the inhibition mechanism of intestinal absorption (competitive versus non-competitive), if present. Blood (10 ml) was drawn from an indwelling venous catheter pre-dosing and at 0.25, 0.5, 1, 2, 3, 4, 6 and 8 hr following a single oral dose of amoxicillin with 8 oz water or CJC. Serum was separated by centrifugation at 3000 rpm and stored at -78°C until analysis. Urine samples were collected just before and at 2-hour intervals for 8 hours post antibiotic dosing.
The cefaclor-CJC interaction was investigated in a similar crossover randomized study. Subjects took a single oral dose of 500 mg cefaclor with 12 oz water or CJC after an overnight fast. Treatments were separated by one week. For the juice treatment, subjects took additional 12 oz CJC twice daily for two days prior to the study day. A standard lunch was provided four hours post-dosing to minimize any interference from on September 12, 2017 by guest http://aac.asm.org/ Downloaded from food effects. Blood (10 ml) was drawn from an indwelling venous catheter into prechilled heparin coated tubes prior to and at 0.25, 0.5, 1, 1.5, 2, 3, 4 and 6 hours after antibiotic dosing. Plasma samples were immediately separated at 4°C and stored at -78°C in cryovials containing 25% glacial acetic acid (100 µl per ml plasma). Urine samples were collected just before and at 2-hour intervals for 6 hours post dosing, and were stored at -78°C until analysis.
Sample analysis Amoxicillin concentrations in serum and urine were analyzed by previously reported HPLC methods using either mass spectrometry (LC-MS) or UV detection (2) . Cefaclor concentrations in plasma were analyzed by a modified LC-MS method of amoxicillin assay. Fifty µl plasma sample was mixed with 80 µl ion pairing reagent (1% triethylamine and 1% acetic acid), 10 µl 5% acetic acid and 20 µl internal standard cefadroxil (40 µg/ml), which was then left standing at room temperature for 5 min. One ml acetonitrile was added to precipitate the plasma proteins. was linear over the tested concentration range (0.05-10 µg/ml) and the limitation of detection of the assay was 0.02 µg/ml. The intra-and inter-day variation was found to below 6% and 15%.
Urine cefaclor concentrations were quantified by a HPLC-UV method. Forty µl urine samples were acidified with 25 mM phosphoric acid and mixed with internal standard cefadroxil (1 mg/ml). Ten µl of sample was injected onto a Restek Ultra Aqueous C 18 column (150 mm x 4.6 mm, 5 µm, Restek Corp, PA) and cefaclor was detected at 265 nm. Chromatographic separation was achieved by gradient elution of mobile phase consisting of KH 2 PO4 solution (20 mM, pH=3.3) and methanol. The standard curve was linear in the tested range (12.5-600 µg/ml) and the detection limit of the assay was 8 µg/ml. The intra-and inter-day assay precision was below 5% and 9%. 
Non-compartmental pharmacokinetic analysis
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where D is the dose. S is the shape parameter (unitless) that defines the overall form of the distribution (from a single exponential to a combination of exponential increase and decay). TD (hour) is the scale parameter, which serves to stretch the distribution function on September 12, 2017 by guest http://aac.asm.org/ Downloaded from along the abscissa, thus affecting both the peak and the time-to-peak of absorption.
Serum concentration data were fitted by a one-compartment model with Weibull absorption and first order elimination as
The study design, with each subjects exposed to all four treatments, allowed us to model 
Results
Amoxicillin-juice interaction
Amoxicillin non-compartmental pharmacokinetic analysis Eighteen women participated in the amoxicillin-juice interaction study with mean (± SD) age of 28 ± 5 years and body weight of 55 ± 12 kg. The mean serum amoxicillin concentration-time profile after 500 mg and 2 g oral dose is shown in Figure 1A . Amoxicillin apparent CL/F increased from 347 ± 75.2 ml/min at a 500 mg dose to 560 ± 112 ml/min at a 2 g dose (P<0.05). In contrast, the mean amoxicillin CL R values (218 vs. 227 ml/min) were similar between the two doses ( among eighteen subjects was detected in the intra-individual AUC change between the two treatments at both doses ( Figure 1B) . The observation indicated a minimal effect of cranberry juice on amoxicillin oral absorption. Nonetheless, co-administration of cranberry juice did result in a significant delay in amoxicillin T max (P<0.01), suggesting a slower absorption rate in the presence of juice. Neither amoxicillin elimination T 1/2 nor the 8-hour cumulative urinary excretion differed between the control and juice treatments, and there was no significant difference in amoxicillin CL R (Table 1) . Table 2 .
Amoxicillin population pharmacokinetic analysis
Population pharmacokinetic results were found to agree well with those derived from non-compartmental analysis (Table 3) . Compared to control, a respective 41%, 28%
and 69% increase in Weibull absorption parameter TD was predicted following juice coon September 12, 2017 by guest http://aac.asm.org/ Downloaded from administration, higher amoxicillin dose, or combined juice co-administration and higher amoxicillin dose. The increase in TD correlated well with the T max increase observed with co-administration of juice. As an altered TD affects both the magnitude of the peak and the time-to-peak in the absorption profile, the TD increases following juice coadministration resulted in a 15.1-16.2% reduction in C max and 28.6-29.4% increase in T max compared to water control at each dose (Table 3 ). Simulated amoxicillin concentration-time courses based on the population pharmacokinetic model are depicted in Figure 2 .
The model also provides a prediction for dose-dependent relative bioavailability which can be validated using urine excretion data. In particular, assuming constant renal clearance and given the total amount excreted, Ae ∞ , we have 
The values in Table 1 suggest that renal clearance is not significantly changed between low and high dose; thus, ratio of the low and high dose CL/F estimates approximates relative bioavailability:
CL F F CL F F =
Our population pharmacokinetic estimates of CL/F support this hypothesis and were consistent with the independent estimate (66%) obtained from the urinary excretion data.
Cefaclor-juice interaction
Cefaclor noncompartmental pharmacokinetic analysis The subjects (n=18) enrolled in cefaclor study had a mean age of 31.7 ± 7.4 years and body weight of 58.7 ± 12.1 kg. Figure 3A (Table 4) were in agreement with the literature values (20, 27) . Similar to amoxicillin, we observed a significant decrease in cefaclor C max values (P<0.01) and a slightly longer T max (P>0.05) with the concomitant use of cranberry juice, suggesting a slower absorption rate in the presence of the juice. However, there was no difference in the mean AUC (20.4 versus 21.0 µg•hr/ml) between water and CJC treatment. Bioequivalence between CJC and control was examined using the same method as for amoxicillin analysis. 90% CI of the log transformed treatment ratios of both AUC (0.922, 1.013) and C max (0.807, 0.940) were within the bioequivalence bounds of 80% to 125% of the control. The intra-subject cefaclor AUC changes between juice co-administration and control are shown in Figure   3B . While a slightly reduced AUC in the presence of CJC was observed in the majority of subjects, three subjects also exhibited 10-20% AUC increase. We did not observe significant difference in cefaclor urinary recovery (ƒ e at 75%) and CL R (306.6 ± 60.2 ml/min) between the control and juice treatment.
Cefaclor population pharmacokinetics Cefaclor population pharamacokinetic analysis was performed using the same approach described for amoxicillin analysis. The addition of BOV was initially significant (p<0.05) on parameters CL/F, S and TD; thus BOV was only included in the base model for these three parameters ( Table 5) As shown in Table 6 , estimates of the final cefaclor population pharmacokinetic model parameters agreed well with those obtained from noncompartmental analysis.
Similarly to the amoxicillin analysis, the population modeling enabled more mechanistic quantification of the pharmacokinetics. The Weibull absorption parameter TD was predicted to increase 22.7% with juice co-administration, which resulted in a 10% increase in calculated T max and an 8.7% decrease in C max . Figure 4 shows simulated cefaclor serum concentration-time curves using the population pharmacokinetic typical parameter values. 
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A number of studies have reported incidences of apple, orange and grapefruitdrug interactions (7, 8, 22, 30) . The potential effect of cranberry juice on drug transporters had not been investigated prior to our study. Given the involvement of drug transporters in the active intestinal absorption and renal excretion of the β-lactams, in the present study we examined their interaction potential with CJC in healthy women. Two antibiotics exhibiting different absorption characteristics were chosen for the studies.
Based on the dose-dependent absorption, amoxicillin absorption is shown to be mediated by passive diffusion and active transport; while being more hydrophilic, cefaclor intestinal absorption is mainly an active process (4).
Following concurrent CJC consumption at 8-12 oz, the common doses used for UTI prophylaxis, we did not observe a significant difference in amoxicillin and cefaclor AUCs in the female subjects. Hence, regular strength CJC at the usually consumed quantity has little effect on the extent of amoxicillin and cefaclor oral absorption. In view of our positive in vitro finding of CJC hPepT1 inhibition, the negligible in vivo juice effect may be explained by sufficient GI fluid dilution of the ingested juice as well as limited residence of the inhibitory components of CJC in the small intestine. Both factors would reduce the extent and duration of CJC inhibition in vivo. In addition, passive diffusion of the amoxicillin across the intestinal epithelium is also likely to lower the magnitude of any transporter-based interaction. Even though CJC did not affect the extent of absorption, our non-compartmental model analysis suggested a slower absorption rate of these antibiotics in the presence of the juice. This was substantiated by our population pharmacokinetic analysis which allowed us to fully model C max and T max changes following juice administration. Cranberry juice intake is predicted to lead to on September 12, 2017 by guest http://aac.asm.org/ Downloaded from notable T max increase and C max decrease for both amoxicillin and cefaclor (Figure 2 and   4) . The underlying mechanism(s) of the absorption rate change is not known. It could be the result of a modest juice inhibition of hPepT1, which affects only the rate but not the extent of the absorption. We also cannot rule out the possibilities of other non-specific juice effects in the gut such as altered drug dissolution rate or ionization due to changes in gastric pH. 
